Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
postapproval marketing
Pharma
Sanofi, GSK, Pfizer and BI can't escape Zantac suits, court says
Even after the global Zantac recalls and the associated controversy, the courtroom saga over the medicine's risk is just getting started.
Eric Sagonowsky
Oct 8, 2021 10:55am
Biogen reps banned from neurology clinics over Aduhelm fallout
Sep 22, 2021 6:44pm
Biogen's latest Alzheimer's ad provokes fresh concerns
Jul 27, 2021 2:18pm
Nabriva scores its first FDA nod with novel antibiotic Xenleta
Aug 19, 2019 12:26pm
Acadia readies new round of Nuplazid DTC
Aug 4, 2019 10:48am
Does a $400M-plus cash raise put Amarin buyout out of reach?
Jul 22, 2019 11:45am
